Latest Food & Drug Administration news
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Proposes Ban on a “Useless” Decongestant, Phenylephrine
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
posted October 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
Weight Cycling Linked to Increased Loss of Muscle Volume 
Compounded GLP-1 Receptor Agonists Remain Widely Available 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
